Radiant’s Multabody™ platform enables multi-valent, multi-specific antibodies that have the potential to transform the treatment of cancer, inflammation, infections and other heterogeneous diseases. This breakthrough in antibody engineering combines avidity – superior binding power – with multi-specificity to create multifunctional biologics with the potential to unlock biology not achievable with current antibodies. Multabodies are a new class of biologics built on a modular, fully human scaffold, simplifying development while leveraging existing antibody manufacturing processes. We are rapidly advancing this superior next-generation therapeutic platform for a variety of indications. Learn more at radiantbio.com.
Company Details
- Employees
- 26
- Founded
- 2020
- Address
- Toronto, On, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://radiantbio.com
- Keywords
- Biotechnology, antibody, biologics, oncology, inflammation, antibodies, drugdiscovery, Canadianbiotech.
- HQ
- Toronto, ON
Radiant Biotherapeutics Questions
Radiant Biotherapeutics's website is https://radiantbio.com
Radiant Biotherapeutics's LinkedIn profile is https://ca.linkedin.com/company/radiantbiorx
Radiant Biotherapeutics has
26 employees.
View email and phone details for 26
employees at Radiant Biotherapeutics.
Radiant Biotherapeutics's industry is
Biotechnology Research
Radiant Biotherapeutics's top competitors are
Xencor,
Superluminal Medicines Inc.,
Zenas Biopharma,
Oruka Therapeutics,
Spectrawave, Inc.,
Pantera,
Bicara Therapeutics,
Candid Therapeutics,
Onl Therapeutics,
Mbx Biosciences, Inc..
Radiant Biotherapeutics's categories are Biotechnology Research
Radiant Biotherapeutics's founding year is 2020
